GB
Girish Basavaraju
About Girish Basavaraju
Data last updated:
Girish Basavaraju is a Director at Rimo Pharmaceuticals Private Limited (since 2019), Director at Akihiro Pharmaceuticals Private Limited (since 2024) and Designated Partner at Nectamed Laboratories Llp (since 2017). The companies operate in Pharma, Paper and Electrnoics. The largest current company by reported revenue is Rimo Pharmaceuticals Private Limited at ₹3.53 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Apr 2019 | 2019 | ₹3.53 Cr (FY 2025) | Active | |
| Director | 16 Aug 2024 | 2024 | Active | ||
| Designated Partner | 28 Sep 2017 | 2017 | Active |
Board colleagues of Girish Basavaraju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bilaguli Renukananda Divya | 10446834 | Rimo Pharmaceuticals Private Limited | Director |
| Nandakumar Bhuvaneshwari | 10446346 | Rimo Pharmaceuticals Private Limited | Director |
| Thuraganur Mahadevu Manjunath | 07921937 | Rimo Pharmaceuticals Private Limited , Akihiro Pharmaceuticals Private Limited and 1 more | Director |
| Amruthur Ranganatha Hemanth Kumar | 11206069 | Akihiro Pharmaceuticals Private Limited | Director |
| Anantharamaiah Sudeendra | 05320830 | Nectamed Laboratories Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Girish Basavaraju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Girish Basavaraju
Girish Basavaraju currently holds 3 directorships: Rimo Pharmaceuticals Private Limited (Director, since 10 Apr 2019, revenue ₹3.53 Cr (FY 2025)); Akihiro Pharmaceuticals Private Limited (Director, since 16 Aug 2024); Nectamed Laboratories Llp (Designated Partner, since 28 Sep 2017).
Girish Basavaraju was first appointed on 28 Sep 2017 as Designated Partner at Nectamed Laboratories Llp. The most recent appointment on record is 16 Aug 2024 at Akihiro Pharmaceuticals Private Limited.
The current boards of Girish Basavaraju's companies include Bilaguli Renukananda Divya (Rimo Pharmaceuticals Private Limited), Nandakumar Bhuvaneshwari (Rimo Pharmaceuticals Private Limited), Thuraganur Mahadevu Manjunath (Rimo Pharmaceuticals Private Limited), Amruthur Ranganatha Hemanth Kumar (Akihiro Pharmaceuticals Private Limited), Anantharamaiah Sudeendra (Nectamed Laboratories Llp).